Researchers at the Paul-Ehrlich-Institut as part of an international consortium have uncovered a mechanism that is based on the activation of mobile genetic elements (retrotransposons) in the genome and leads to damage and death of cells of the retina in patients suffering from dry AMD.
» DNA of Transposable Elements Identified as Cause for Age-related Macular Degeneration (AMD)
It is with a heavy heart that we share the news that our colleague, Miss Victoria Lendrum Cohen, MA, MB BChir, FRCOphth passed away shortly before Christmas. Her sudden disappearance at such a young age comes as great shock to us and she will be missed dearly.
» In Memoriam: Victoria Lendrum Cohen
The biotechnologist Prof. Volker Busskamp from the University of Bonn Eye Clinic receives a 2020 "Proof of Concept Grant" from the European Research Council (ERC).
» With human stem cells against blindness
Kate Grieve, Scientific Director of the “Paris Eye Imaging” ocular imaging unit has just been awarded by the European Commission a 5-year “ERC Consolidator Grant”, which will enable her to pursue the development of optical imaging.
» Development of non-invasive optical measurements of retinal cell function in the living human eye
Retinal ganglion cells (RGCs) are the bottleneck through which all visual impressions flow from the retina to the brain. A team from the Max Planck Institute of Neurobiology, University of California Berkeley and Harvard University created a molecular catalog that describes the different types of...
» New study decodes the molecular diversity of neurons in the zebrafish retina
The Retinal Medicine Clinical Research Award is an annual initiative sponsored by EURETINA to support and encourage independent clinical research in the field of retinal medicine.
» Retinal Medicine Clinical Research - Funding Call 2021
We are very pleased to have launched the IoO Annual Review, covering some of the outstanding work we achieved in the 2019-2020 academic year.
» UCL Institute of Ophthalmology Annual Review 2019-2020 is out
In a virtual award ceremony (available on EndBlindness2020.com)) Botond Roska has been awarded a Sanford and Susan Greenberg Visionary Prize to End Blindness “for uniquely valuable research having the greatest impact toward advancing restoration of vision in human patients.”
» Botond Roska receives Greenberg Visionary Prize to End Blindness
Novartis Ophthalmology - Reimagining the treatment and prevention of visual impairment and blindness. €500,000 is available to fund a minimum of 10 awards for up to €50,000 each.
» XOVA eXcellence in Ophthalmology Vision Awards applications are now open!
Injecting a gene therapy vector into one eye of someone suffering from LHON, the most common cause of mitochondrial blindness, significantly improves vision in both eyes, scientists have found.
» Gene therapy injection in one eye surprises scientists by improving vision in both
